Centre of Evidence Based Dermatology

CommPharmBannerImage

Community Pharmacy:
Setting priorities
for dermatology 

 

Overview

  • Skin disorders are highly prevalent and represent a significant part of the primary care workload.
  • Community pharmacists already play an important role in this (seeing skin conditions on a daily basis) but this provision could be enhanced and/or more targeted.
  • There is a need for research to support the development of community pharmacy provision in dermatology, but a lack of clarity about those topics and areas which should be prioritised in this. 

 

Full results paper (BMJ Open)
Top 10 infographic
 

 

 Top 10 questions 

 
  1. Would dedicated resources improve the identification of skin conditions in community pharmacy? 
  2. Would dedicated resources improve the identification of skin conditions in skin of colour in community pharmacy? 
  3. Would dedicated resources support community pharmacists to effectively refer skin conditions that require urgent or more specialist attention? 
  4. How can community pharmacists work most effectively with other healthcare professionals in the identification and management of skin disease? 
  5. Could a wider range of products and treatments for skin conditions be made available via community pharmacy? 
  6. Would dedicated resources support community pharmacists in the management of skin conditions? 
  7. In what ways are community pharmacists currently involved in the identification and management of skin conditions? 
  8. What are the known benefits of community pharmacy involvement in the identification and management of skin conditions? 
  9. How competent are community pharmacists in the identification and management of skin conditions? 
  10. What could be done to raise awareness of the skills that community pharmacists have with regards to the identification and management of skin conditions? 
 

 

Project Plan

A six month stakeholder consultation exercise with community pharmacists, general practitioners and members of the public to establish those research questions which are priorities in the development of community pharmacy dermatology provision.

A series of workshops to explore the research that stakeholders would find beneficial to support the development of new or enhanced provision for skin disorders. A concluding meeting where research prioritises are decided upon, and opportunities for practice changing research identified.

The project is funded by the NIHR National School for Primary Care Research.

Project Team

The project is led by Dr Paul Leighton and Dr Jane Harvey at the Centre of Evidence Based Dermatology at the University of Nottingham - the CEBD has an international reputation for independent research into the treatment and prevention of skin disease.

Local collaborators of the PSP include Professor Claire Anderson and Dr Matthew Boyd from the University of Nottingham School of Pharmacy; and, Professor Tony Avery from the School of Medicine.

Other collaborators are based at Aston University, Bristol University and Southampton University.

 

Centre of Evidence Based Dermatology

The University of Nottingham
Applied Health Research Building
University Park, Nottingham
NG7 2RD


telephone: +44 (0) 115 84 68631
email: cebd@nottingham.ac.uk